Evidence map›Paper›PMID 37227617›Full record

ArticleInternational ophthalmology2023

Binocular metamorphopsia in patients with branch retinal vein occlusion: a multi-center study.

Rie Osaka, Yuki Muraoka, Daisuke Nagasato, Yoshinori Mitamura, Naomi Nishigori, Tomoaki Murakami, Kiyoshi Suzuma, Hitoshi Tabuchi, Akitaka Tsujikawa

Open access · hybridAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in International ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Rie OsakaDepartment of Ophthalmology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Yuki MuraokaDepartment of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan. muraoka@kuhp.kyoto-u.ac.jp.
Daisuke NagasatoDepartment of Ophthalmology, Saneikai Tsukazaki Hospital, Himeji, Japan.
Yoshinori MitamuraDepartment of Technology and Design Thinking for Medicine, Hiroshima University Graduate School, Hiroshima, Japan.
Naomi NishigoriDepartment of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Tomoaki MurakamiDepartment of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kiyoshi SuzumaDepartment of Ophthalmology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Hitoshi TabuchiDepartment of Ophthalmology, Saneikai Tsukazaki Hospital, Himeji, Japan.
Akitaka TsujikawaDepartment of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kyoto University · JPHiroshima University · JPKagawa University · JPTokushima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe pathology of branch retinal vein occlusion (BRVO), a retinal circulatory disease, is related to monocular metamorphopsia-related vision impairment of the affected eyes, but the association of binocular metamorphopsia in such patients is unclear. This study aimed to examine the frequency of binocular metamorphopsia and its association with the clinical characteristics of patients with BRVO.

methodsA total of 87 patients who were treated for BRVO-associated macular edema (ME) were included in this study. At baseline and 1 and 3 months after the initiation of anti-vascular endothelial growth factor (VEGF) treatment, we quantified metamorphopsia in the affected eyes and binocular metamorphopsia using the M-CHARTS

resultsAt baseline, 53 and 7 patients had metamorphopsia in the affected eyes and binocular metamorphopsia, respectively. Although the visual acuity improved significantly after the initiation of anti-VEGF treatment, the mean M-CHARTS score in the affected eyes did not change from the baseline score. At 3 months, 9 patients showed binocular metamorphopsia; it was significantly associated with metamorphopsia in the affected eyes with a 95% confidence interval of 0.021-0.122 (β = 0.306, p = 0.006).

conclusionMetamorphopsia in the affected eyes can cause binocular metamorphopsia in patients with BRVO-ME.

Indexed as

Macular EdemaRetinal Vein OcclusionAngiogenesis InhibitorsEyeHumansIntravitreal InjectionsRetrospective StudiesTomography, Optical CoherenceVascular Endothelial Growth Factor AVision DisordersAngiogenesis InhibitorsVascular Endothelial Growth Factor ABinocular metamorphopsiaBranch retinal vein occlusionMacular edemaM-CHARTSMetamorphopsia

Identifiers

PMID37227617
PMCPMC10400688
OpenAlexW4378173029

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.